SG11201808487UA - Carboxylic acids for early childhood application - Google Patents

Carboxylic acids for early childhood application

Info

Publication number
SG11201808487UA
SG11201808487UA SG11201808487UA SG11201808487UA SG11201808487UA SG 11201808487U A SG11201808487U A SG 11201808487UA SG 11201808487U A SG11201808487U A SG 11201808487UA SG 11201808487U A SG11201808487U A SG 11201808487UA SG 11201808487U A SG11201808487U A SG 11201808487UA
Authority
SG
Singapore
Prior art keywords
international
pct
application
english
patient
Prior art date
Application number
SG11201808487UA
Other languages
English (en)
Inventor
Bettina Ernst
Original Assignee
Proponent Biotech Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proponent Biotech Gmbh filed Critical Proponent Biotech Gmbh
Publication of SG11201808487UA publication Critical patent/SG11201808487UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201808487UA 2016-05-17 2017-05-17 Carboxylic acids for early childhood application SG11201808487UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16169888 2016-05-17
PCT/EP2017/061835 WO2017198705A1 (en) 2016-05-17 2017-05-17 Carboxylic acids for early childhood application

Publications (1)

Publication Number Publication Date
SG11201808487UA true SG11201808487UA (en) 2018-10-30

Family

ID=56014858

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201808487UA SG11201808487UA (en) 2016-05-17 2017-05-17 Carboxylic acids for early childhood application

Country Status (13)

Country Link
US (1) US20190160030A1 (es)
EP (1) EP3458044A1 (es)
JP (1) JP2019516798A (es)
KR (1) KR20190008236A (es)
CN (1) CN109152755A (es)
AU (1) AU2017266729A1 (es)
BR (1) BR112018072183A2 (es)
CA (1) CA3020558A1 (es)
CL (1) CL2018003269A1 (es)
MX (1) MX2018013474A (es)
RU (1) RU2018143557A (es)
SG (1) SG11201808487UA (es)
WO (1) WO2017198705A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110403914A (zh) * 2019-06-13 2019-11-05 兰溪市立顺生物有限公司 用于儿童早期应用的羧酸

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0617191D0 (en) * 2006-08-31 2006-10-11 York Pharma Plc Improvements in pharmaceutical compositions
AU2007214300B2 (en) * 2007-08-29 2009-11-05 Sunny Pharmtech, Inc. Method for Ameliorating Pruritus
US20130004590A1 (en) * 2011-06-28 2013-01-03 Lin Connie B Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation

Also Published As

Publication number Publication date
MX2018013474A (es) 2019-08-12
CN109152755A (zh) 2019-01-04
EP3458044A1 (en) 2019-03-27
JP2019516798A (ja) 2019-06-20
CL2018003269A1 (es) 2019-02-22
BR112018072183A2 (pt) 2019-02-12
WO2017198705A1 (en) 2017-11-23
AU2017266729A1 (en) 2018-10-18
KR20190008236A (ko) 2019-01-23
RU2018143557A (ru) 2020-06-17
CA3020558A1 (en) 2017-11-23
US20190160030A1 (en) 2019-05-30

Similar Documents

Publication Publication Date Title
SG11201908330PA (en) Farnesoid x receptor agonists and uses thereof
SG11201407961WA (en) Risperidone or paliperidone implant formulation
SG11201811470PA (en) Pyrazolopyrimidine derivatives as kinase inhibitor
SG11201909155VA (en) Ask1 inhibitor compounds and uses thereof
SG11201407971QA (en) Paliperidone implant formulation
SG11201900349VA (en) Somatostatin modulators and uses thereof
SG11201810628XA (en) Nasal pharmaceutical compositions with a porous excipient
SG11201808237UA (en) Substituted indole compound derivatives as dengue viral replication inhibitors
SG11201901534VA (en) Combination therapy with controlled-release cnp agonists
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201808270PA (en) Substituted indoline derivatives as dengue viral replication inhibitors
SG11201811442UA (en) Formulation of a peptide vaccine
SG11201907604UA (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
SG11201908512YA (en) Somatostatin modulators and uses thereof
SG11201407397WA (en) Formulations and methods for vaginal delivery of antiprogestins
SG11201808138YA (en) Substituted indole derivatives as dengue viral replication inhibitors
SG11201907804QA (en) Pharmaceutical composition comprising selexipag
SG11201807597UA (en) Methods of treating depression using orexin-2 receptor antagonists
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201901986SA (en) Process for the manufacture of a solid pharmaceutical adminstration form
SG11201804587QA (en) Isoindole compounds
SG11201811580SA (en) Compositions, devices, and methods for the treatment of alcohol use disorder
SG11201805755SA (en) Methods of administering hepcidin
SG11201901048VA (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
SG11201900214UA (en) Iso-citrate dehydrogenase (idh) inhibitor